Abstract. Activation of developmental pathways has been recognized as a key mechanism for tumourigenesis and, hence, might be a valuable target for otherwise difficult to treat tumour entities such as biliary tract cancer (BTC). Therefore, we performed a comprehensive analysis of the Wnt signalling pathway in 9 BTC cell lines on cell blocks, xenograft tumours and on human tissue microarrays by realtime reverse transcription PCR and by immunochemistry. Furthermore, the effects of pharmacological pathway inhibition were investigated. As a result we found a significant positive correlation of Wnt pathway activation with cyclin D1 expression and the proliferation parameters Ki67, cell cycle distribution, and growth kinetics as well as the mesenchymal marker vimentin and an inverse correlation with E-cadherin in BTC cell lines in vitro and in vivo. In human BTC samples loss of membranous ß-catenin, an indicator of active Wnt signalling, correlated with vimentin expression and advanced tumour stage or metastasis, whereas membranous localisation of ß-catenin was associated with the differentiation marker cytokeratin-8/18 and differentiated tumour morphology (ductal or mixed type BTC). In addition, Wnt pathway inhibition by DMAT effectively reduced viability in all cancer cell lines, most effectively in those showing cytoplasmatic ß-catenin localisation, i.e. active Wnt signalling. In summary, activation of the Wnt pathway is associated with high proliferation, dedifferentiation and a solid morphology in human biliary tract cancer cell lines both in vitro and in vivo, and in human BTC tissues. Further investigation of the mechanism(s) of Wnt pathway activation and its inhibition may provide new molecular treatment strategies for biliary tract cancer.
Introduction
Biliary tract cancer (BTC) still has a poor prognosis. The only curative treatment is surgical resection with a median 5-year survival rate of only 35% (1, 2) . In the majority of patients (70-80%), however, local tumour extension or metastases preclude complete resection. For non-resectable BTC, palliative chemo/radiochemotherapy or photodynamic tumour ablation achieve median survival times up to 18 to 28 months (2-4). These therapies, however, fail to inhibit BTC tumour cell proliferation in the long-term. Molecular growth characteristics, and pharmacologic inhibitors, of BTC could indicate potential targets for molecular therapy in this orphan tumour disease.
Recent studies highlight a role of developmental signalling pathways for tumourigenesis demonstrating that tumour cells employ these signalling mechanisms for cell proliferation and metastasis (5, 6) . Developmental pathways such as hedgehog and Wnt exert specific pathway-dependent effects on expression of genes involved in gastrointestinal tumourigenesis (7, 8) . The Wnt pathway is critical to embryonic development in a variety of organisms by controlling the expansion of cells with predefined fates (9) . The most wellknown example for involvement of Wnt signalling in tumourigenesis is adenomatous polyposis coli where the responsible germline mutation affects the gene for APC (adenomatous polyposis coli), a central regulatory component of the Wnt pathway (10) . In subsequent studies, the involvement of deregulated Wnt signalling could be demonstrated in a variety of other tumours based on the discovery of mutations in other components of the pathway such as axin and ß-catenin (ßCat) (11) . Active Wnt signalling usually results in cytoplasmatic stabilisation of ßCat leading to the accumulation and nuclear translocation of ßCat where it complexes with the T cell factor/lymphoid enhancer-binding factor (TCF/LEF) and induces transcription of Wnt target genes (11) (12) (13) . This type of canonical Wnt signalling is regularly initiated by binding of one of the 19 to date known secreted Wnt proteins (14) to two distinct membrane receptors, i.e. the frizzled proteins (Frz) and low-density lipoprotein receptor related proteins (LRPs). Receptor activation inactivates a destruction complex consisting of APC, axin and GSK3 (glycogen synthase kinase 3) thus preventing the phosphorylation of ßCat by GSK3, its ubiquitinylation and, eventually, proteasome-mediated degradation (reviewed in ref. 13 ). The role of Wnt signalling in tumourigenesis is based on transcriptional activation of targets relevant to tumour initiation and progression. These include cyclins and c-myc, antiapoptosis factors such as survivin and transcription factors such as Snail or Slug inducing epithelial-to-mesenchymal transition (EMT) or matrix metalloproteinases for tumour invasion and metastasis (15) . Therefore, targeting the Wnt pathway has been suggested to represent a promising antitumour strategy (16, 17) .
As BTC is an orphan tumour, well-characterized preclinical models are of great value for identification of novel therapeutic targets. As the Wnt pathway has not been studied systematically in BTC, we investigated, whether the Wnt canonical pathway is expressed and plays a major role in the growth potential and de-/differentiation characteristics of biliary tract cancer cells in vitro (in nine BTC cell lines) and in their corresponding xenograft tumour model. In addition, in tissue microarrays (TMA) of human BTC we studied the expression of Wnt pathway activation related to tumour differentiation grade and clinical staging of the original tumour. The aim was, to study the role of the Wnt pathway for progression of BTC and analyse the effects of its inhibition in this model system.
Materials and methods
Substances, cell lines and culture conditions. DMAT (2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole; Wnt inhibitor), PI and RNase (propidium iodide and ribonuclease A; cell cycle analysis), MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide; cytotoxicity assay), crystal violet and glutaraldehyde (growth assay) were obtained from Sigma-Aldrich (Vienna, Austria). Bile duct carcinoma cell lines CCLP-1 (18), CCSW-1 (18), BDC (19) , Egi-1, SkChA-1 (20) , TFK-1 (21) and gallbladder cancer cell lines MzChA-1 (20) , MzChA-2 (20), Wittier (22) were cultured as described previously (23) using Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS; PAA Laboratories, Pasching, Austria). Cell lines and human tissue samples are collectively referred to as biliary tract cancer (BTC) in the following (24) . See Table I for original tumour grading.
Quantitative real-time RT-PCR. Cells were lysed by addition of TRIzol reagent (Invitrogen, Lofer, Austria) to 10 cm diameter petri dishes and total RNA was isolated according to the manufacturer's instructions. An aliquot was subsequently subjected to DNase treatment and reverse transcription (RQ RNase-Free DNAse and ImProm-II RT system, Promega, Mannheim, Germany) using random primers (Invitrogen), according to the manufacturer's instructions. Quantitative real-time reverse transcriptase-PCR (qRT-PCR) was employed to analyze expression of Wnt-specific mRNAs coding for ligands (Wnt1/3/3a/8a), receptors (Frz1/3/7), and transcription factors [Lef-1, Tcf7, Tcf7L1/2; lymphoid enhancerbinding factor 1, transcription factor 7 (-like1/2, T cellspecific)] using an iCycler real-time PCR thermocycler (BioRad Laboratories, Hercules, CA). Identity and specificity of the product were checked by polyacrylamid gel-electrophoresis/silver stain and by negative first-deviation plots of the melting curve, respectively. Calculation of the relative expression of each transcript (X) was performed using the formula 2 -ΔCt (25) , where ΔCt=C t(x) -C t(H) with polymerase (RNA) II (DNA directed) polypeptide A as the housekeeping gene (H) (26) . Primer sequences are available on request.
Cell cycle analysis and growth assay. Cellular DNA content was analyzed using a FACSCanto II flow cytometer as described previously (27) (BD Biosciences, Schwechat, Austria; data analysis: WinMDI software Version 2.8). For growth analysis cells were seeded at a density of 1x10 4 per well in 96-well transparent microplates (Greiner Bio-One, Kremsmünster, Austria) in 100 μl DMEM (10% FBS). The crystal violet assay was used to assess the change in cell mass (proliferation) as described (28) . Absorbance was read using an Infinite M200 microplate reader (Tecan, Groedig, Austria) at 590 nm, corrected by subtraction of blank values (wells treated as above, without cells) and related to the initial time point set to 1 (100%).
Cell block. Cell pellets were resuspended in 200 μl citrate plasma (supplied by the Institute of Transfusion Medicine, PMU, Salzburg, Austria) and 200 μl Thromborel ® S (Siemens Healthcare Diagnostics, Deerfield, IL, USA). After coagulation cells were fixed for 1 h in neutral-buffered saline containing 7% formalin and were then paraffin-embedded.
Xenograft model. Cell lines were harvested, resuspended in sterile physiologic NaCl solution and injected into the flank of 4 to 6-week old NMRI mice (each 3x10 6 cells per mouse/5 mice per cell line; Harlan Winkelmann GmbH, Borchen, Germany) (29, 30) . Animals were kept in a lightand temperature-controlled environment and provided with food and water ad libitum. Animals were sacrificed at mean day 45 (range 39-46) by cervical dislocation and tumour samples were fixed in 10% phosphate-buffered formalin. Ethical approval was granted before any animal experiment by the Regional Government of Lower Franconia, Würzburg, Germany (No. 54-2531.31-9/06).
Histology. Hematoxylin-eosin (H&E) staining was used to evaluate basic histomorphology of the specimens, especially ductal and solid morphology which was assigned if the tumour displayed ductal and solid formations in >75% of the whole specimen, respectively. The epithelial mucopolysaccharides were detected by the PAS reaction (score 0-3: 0 for negative, 1 for low (0-25%), 2 for moderate (25-50%) and 3 for strong (>50%) reaction). The content of extracellular collagen was estimated using the chromotrope-aniline blue (CAB; score 0-3 for negative to strong staining) (31) .
Immunocyto/histochemistry (ICC/IHC).
Cell blocks as well as formalin-fixed and paraffin-embedded xenograft tumour samples were cut into 5 μm sections and, together with the human BTC tissue microarrays (AccuMax™ Array, Cat. No. A205; via BioCat, Heidelberg, Germany), deparaffinised using graded alcohols. Antigen retrieval was performed by heat-induced epitope retrieval in pH 9.0 antigen retrieval buffer (Dako, Glostrup, Denmark) at 95˚C for 60 min. Endogenous peroxidase blocking was carried out for 10 min with peroxidase-blocking reagent (Dako). Subsequently, primary antibodies were applied for 30 min at RT. Primary rabbit and mouse antibodies were detected using the EnVision Detection System (Dako), for primary goat antibodies detection was performed using a biotinylated rabbit anti-goat antibody (Dako, 1:400) and StreptABComplex/HRP Duet kit (Dako, 1:300). Visualization was performed using diaminobenzidine (DAB) as the chromogen substrate (Roche Molecular Biochemicals, Mannheim, Germany) according to the manufacturer's instructions. Slides were counterstained with hematoxylin. The stained slides were digitalized using the ImageAccess Enterprise 5 software (Imagic Bildverarbeitung, Glattbrugg, Switzerland). Images were evaluated using a modified quickscore method (32) by multiplication of the intensity (rated 0, 1, 2, 3) and extent (0, 1, 2, 3, 4) of the staining which yields values ranging from 0 (negative) to maximum 12 (3 staining intensity and 100% positive cells). Image evaluation was carried out independently by two investigators (TK and DN). Sources of primary antibodies are available on request.
Cytotoxicity and caspase assay. Cells were seeded at a density of 1.5x10 4 per well (2x10 4 for MzChA-1) in 96-well microplates. After 24 h the cells were washed with 100 μl serum-free DMEM and incubated with 100 μl medium containing 5 μM DMAT or DMSO (solvent control). After 72 h the medium was replaced with 100 μl DMEM containing 0.45 mg.ml -1 MTT and further processed as described previously (33) (absorbance read at 565 nm using the Infinite M200). The signal was corrected for blank values and related to untreated control cells; the final values indicate the fraction of intact and metabolically active cells (34) . For assay of caspase-3, CCLP-1 and Wittier cells were seeded at a density of 3.29x10 5 and 3.95x10 5 per well in 6-well microplates, respectively. Following 24 h incubation, cells were washed with serum-free DMEM and incubated with serum-free DMEM containing 5 μM DMAT. At time points indicated in Fig. 3C , cells were harvested and cell lysates were assayed for caspase-3 enzyme activity using a fluorigenic AMC-DEVD peptide substrate and corrected for overall protein content as described previously (27) .
Statistical analysis. Correlation coefficients were calculated according to Spearman using SPSS v. 16.0 (SPSS GmbH Software, Munich, Germany). Univariate ANOVA (analysis of variance) was used to test for differences between groups of tissue samples. Student's t-test was used for comparison of viability signals.
Results
In vitro proliferation characteristics. Proliferative characteristics by cell cycle and growth analysis indicate high proliferative capacity of all BTC cell lines with the BDC cell line characterized by the highest rate of proliferation (Table I) . Analysis of the cell cycle distribution by flow cytometry largely corresponds to the growth curves obtained for the individual cell lines.
mRNA and protein expression analyses
In vitro analysis (Fig. 1) . For Wnt ligands, only mRNA specific for Wnt3 could be amplified by qRT-PCR (Fig. 1A) ; Furthermore, Lef1 as a transcriptional effector could be detected and quantified only in CCSW-1, EGI-1, MzChA-1 and SkCHA-1 cells. Other components of the Wnt pathway Table I . Cell cycle and growth characteristics of BTC cell lines. 
Given as populations mean ± STDEV of three independent determinations; b ± gaussian errors; c linear fit of growth curves (three independent determinations). low levels. At the protein level (Fig. 1B) the expression and intracellular localisation of ßCat shows i) varying pattern between individual cell lines, and ii) a distinct reciprocal staining pattern, i.e. cell lines with predominantly membranelocalizing ßCat (Egi-1, TFK-1 and Wittier) show small scores for cytoplasmatic or nuclear staining and vice versa. Representative images of ßCat staining patterns for cell blocks are shown in Fig. 1E .
The intracellular localisation of ßCat in the different BTC cell lines is associated with the expression of differentiation markers as follows: predominant membranous ßCat expressing cells such as Wittier and TFK-1 show high Ck7, -8/18, -19 and E-cadherin, but low levels of vimentin whereas mainly cytoplasmatic ßCat expressing cells such as CCLP-1 show low expression of cytokeratins and E-cadherin, but high levels of vimentin (see also below for correlation analysis).
In vivo analysis (xenograft) (Fig. 1 C and F) . For several cell lines this trend of ßCat expression is preserved also for xenograft tumours. Similar to the above-mentioned results predominantly membranous localising ßCat is seen in cell lines with high cytokeratins as well as E-cadherin and vice versa. Additionally, as shown in Fig. 1D , membranous ßCat expression decreases from ductal to solid growth pattern whereas cytoplasmatic and nuclear ßCat shows an opposite trend. In general, the cell lines can be classified from Fig. 1B and C into two groups by low versus high differentiation characteristics, a distinction which is in line also with xenograft tumour morphology (HE staining) and proliferation status.
Representative images for in vitro and in vivo samples are shown in Fig. 1E and F, respectively.
In vivo analysis (TMA, Fig. 2 ). Immunohistochemistry revealed significant differences between normal and BTC cases for ßCat localisation (Fig. 2C) : for normal tissue ßCat expression was almost exclusively found in the cell membrane whereas BTC tissue samples showed reduced membranous and increased cytoplasmatic ßCat localisation, that corresponded to decreased Ck7 and increased expression of Ki67 (p<0.01) and vimentin (p<0.05) (Fig. 2A) . Analysis by tumour morphology showed a decreasing membranous localisation of ßCat from ductal over mixed (solid/ductal) to solid growth pattern (Fig. 2D) , and an opposite trend for cytoplasmatic ßCat, which was, however not statistically significant. The three different morphologic tumour types differed significantly in the expression of Ck8/18, vimentin and Ki67, as well as in their grading and TNM categories (Fig. 2B) . Representative IHC images for TMA samples are shown in Fig. 2E .
Correlation analysis
In vitro (Table II) . With respect to Wnt pathway activation a number of significant correlations consistently indicates that membranous localisation of ßCat (inactive Wnt signalling) is linked with high differentiation (positive correlation with Ecadherin) and low proliferation (positive and negative correlation with G 0 /G 1 and S/G 2 cell cycle populations, respectively). Cytoplasmatic and nuclear localisation of ßCat, on the contrary, is associated with high proliferation (positive correlation with growth curve, S/G 2 , cyclin D1, Ki67 and low p27) and low or mesenchymal differentiation (positive Table II . Correlation analysis in vitro. 
-------------------------------------------------

------------------------------------------------ßCat
------------------------------------------------
a qRT-PCR (Fig. 1A) ; b Immunocytochemistry, cell blocks (Fig. 1B) ; c p<0.05. Cat, catenin; Ck, cytokeratin; Cyc, cyclin; cyt, cytoplasmatic; ECad, E-cadherin; Frz, frizzled; mem, membranous; nuc, nuclear; Tcf, transcription factor (T cell-specific); vim, vimentin. Table III . Correlation analysis in xenograft tumours. 
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------------------------------------------------ßCat
------------------------------------------------
a qRT-PCR (Fig. 1A) ; b Immunocytochemistry, cell blocks (Fig. 1B) ; c Immunohistochemistry, xenograft tumours (Fig. 1C) ; d p<0.05. AntiTr, ·1-antitrypsin; CAB, chromotrope-aniline blue; Cat, catenin; Ck, cytokeratin; Cyc, cyclin; cyt, cytoplasmatic; ECad, Ecadherin; Frz, frizzled; mem, membranous; nuc, nuclear; Tcf, transcription factor (T cell-specific); vim, vimentin.
-------------------------------------------------
correlation with grading and vimentin). Comparison of differentiation and proliferation parameters in vitro confirmed these relationships: in particular, high differentiation status (by high cytokeratin and E-cadherin and low vimentin expression) is linked with low proliferation capacity, as measured by growth curve, cell cycle distribution and proliferation markers (cyclin D1, Ki67) or with expression of cell cycle inhibitors (p21, p27) (data not shown). In vivo (Table III) . For differentiation parameters similar relationships were found in xenograft tumours. A solid tumour morphology or PAS reactivity correlated with cytoplasmatic and nuclear localising ßCat, and membranous localisation of ßCat corresponded to E-cadherin expression and tumour differentiation. Notably, the mRNA levels of Wnt pathway components (Tcf7 transcription factors and Frz receptors) are often contrary to those of membranous ßCat, as shown for both the in vitro and in vivo situation (Tables II and III) .
Human tissue microarray (Table IV) . IHC analysis of human BTC TMAs confirmed the above-mentioned relationship between Wnt pathway activation and dedifferentiation status (Fig. 2) . As shown in Table IV 
Effects of Wnt pathway inhibition.
In order to investigate whether pharmacological pathway inhibition affects cell viability in vitro, cells were incubated for 72 h with DMAT to inhibit Wnt signalling. This period of drug incubation was chosen to ensure that the MTT signal represents the remaining viable cell fraction at a time point when apoptotic cells no longer contribute to the MTT signal (35) . In preliminary experiments (data not shown) dose-response analyses were performed and the indicated concentration elicited reproducible and significant cytotoxicity. As shown in Fig. 3A , 5 μM DMAT caused a significant decrease in the MTT signal compared to solvent controls in all cell lines, ranging from about 50% (SkChA-1, TFK-1, Wittier) to >90% reduction (CCLP-1). When the cytotoxic efficiency was compared with proliferation and differentiation parameters (Fig. 3B) we found significant positive correlation with cyclin D1 and Ki67 staining as well as negative correlation with Ck7. Interestingly, both cytoplasmatic and nuclear localisation of ßCat was significantly associated with high cytotoxic effects of DMAT. Time-course analysis of the caspase-3 enzymatic activity (Fig. 3C) further indicates that the reduction of viability by DMAT is caused by induction of apoptosis. In CCLP-1 cells the caspase-3 signal reaches a maximum after 8-10 h post incubation with DMAT. In Wittier cells where DMAT is less effective the caspase-3 signal is in range of control sample at all time points analysed. In order to verify DMAT as a specific inhibitor of Wnt signalling, cells treated with 5 μM DMAT were probed for ßCat by immunocytochemistry 5 h post incubation (Fig. 3D) . As indicated by arrows, about 35% of DMAT-treated cells show complete non-reactivity for ßCat whereas almost all cells in control samples (>97%) showed intense cytoplasmatic and nuclear staining. human BTC tissue microarrays yielded three major findings: i) the Wnt pathway is functional to a different degree in all cell lines and in human BTC TMA, ii) activation of the Wnt pathway correlates with decreasing differentiation and increasing proliferation status of BTC, both in vitro and in vivo as well as in human BTC tissues, and iii) pharmacologic inhibition of the Wnt pathway is highly cytotoxic for BTC cells in vitro.
In order to analyse whether the Wnt pathway is active in the experimental BTC model we studied the localisation of ßCat. Accumulation of cytoplasmatic and nuclear ßCat induced by down-regulation of the cytoplasmatic destruction complex is the defining event of active Wnt signalling (11) (12) (13) . Based on this criterion we found that the Wnt pathway is either inactive (preferential membranous ßCat) or active with predominant cytoplasmatic or nuclear ßCat each in a subgroup of the cell lines. This feature is also maintained in corresponding xenograft tumours showing similar grouping of cell lines according to their ßCat localisation. Active Wnt signalling is further confirmed by positive correlation of cytoplasmatic and nuclear ßCat with the growth characteristics, both in vitro and in xenograft tumours, in accordance with the cell cycle-promoting effect of the activated Wnt pathway on gene transcription level.
Cyclin D1 is a well-established target gene of active Wnt signalling (11, 15, 36) , and a growth-promoting mechanism has already been shown for other gastrointestinal tumours (12, 37) . In agreement with our results, nuclear or cytoplasmatic ßCat was found in >50% of cases with intrahepatic cholangiocarcinoma (n=14 out of 24) and the levels of cyclin D1 and tumour size were correlated with ßCat accumulation (38) . Possibly due to the small number of cases, no significant relations could be found between ßCat and tumour differentiation or the macroscopic and histological type (38) . Furthermore, we found an inverse relation of mRNA level of the cyclin-dependent kinase inhibitor p27 KIP1 and the amount of cytoplasmatic ßCat (Table II) , indicating that the expression of p27(KIP1) could be controlled by Wnt in BTC cells. The p27 protein has been described as a negative Wnt target (39, 40) . For the mRNA level of Wnt receptors or transcription factors we could not find similar correlations (Tables II and III) . This discrepancy might be explained by the fact that activation of the Lef/Tcf-like transcription factors by association with nuclear ßCat does not necessarily alter the relative amount of these transcription factors. As discussed below, further evidence for Wnt activation in BTC is provided by the significant cytotoxic effects exerted by pharmacological inhibition in BTC cell lines.
When the localisation of ßCat was related to the histological differentiation of the cell lines we found several significant correlations: increased cytoplasmatic or nuclear ßCat is significantly associated with poor differentiation (high grading) of the original tumour (Table II) , reduced Ecadherin (Tables II and III) and a solid growth type of the xenograft tumour (Table III) . This finding is supported by Settakorn et al (41) who found that reduced membranous ßCat is significantly linked to reduced membranous Ecadherin. Additionally, our analysis indicates that active Wnt signalling is connected with a transition to a mesenchymal phenotype as well as dedifferentiation (high vimentin and low cytokeratin expression, Table III ). The latter is supported by data on other tumour types where disruption of Wnt signalling by a dominant negative Tcf-4 resulted in G1 cell cycle arrest and intestinal differentiation of colorectal cancer cells (42) , and reduced membranous ßCat was linked to loss of differentiation in thyroid tumours (43) . Table IV . Correlation analysis in tissue microarrays. ------------------------------------------------------------------------------------------------ 
Cat, catenin; Ck, cytokeratin; cyt, cytoplasmatic; mem, membranous; morpho, morphology; n.s., not significant; Vim, vimentin.
-
In actual human BTC tissue samples analysis of Wnt pathway activation via ßCat localisation confirmed the key findings of the cell line model. We found that membranous ßCat is significantly decreased when compared to normal biliary epithelium, whereas cytoplasmatic ßCat is frequently found in BTC tissues. These results are in line with published data showing that membranous ßCat is reduced compared to normal biliary epithelium (38, 44, 45) and correlated with loss of differentiation in cancer cells (44) and histological tumour type (45) , and progression in biliary intraepithelial neoplasia (BilIN) and intraductal papillary neoplasm of the bile duct (IPNB) (46) . We further demonstrate that membranous ßCat is linked with high Ck8/18 expression and inversely correlated with advanced tumour stage or metastasis status. For both, human BTC and the xenograft model, we found a consistent connection between ßCat localisation and the tumour morphology. In particular, reduced membranous and increasing cytoplasmatic ßCat is associated with a solid pattern of tumour morphology. As no detailed case history is available for the commercial TMAs used in this study, further analysis for e.g. survival time cannot be provided with these samples. The current study did not address the mutational status of Wnt components. For BTC, published results on mutations in Wnt components are rather controversial. Particularly, mutations in the ßCat, APC and Axin-1 gene were found in some cases of intrahepatic cholangiocarcinoma (38) whereas others studies (45, 47) failed to do so. Therefore, comprehensive studies on the impact of pathwayactivating mutation in Wnt signalling components for tumourigenesis of BTC seem necessary. Taken together, the present study provides firm evidence from experimental models and human BTC samples that Wnt signalling is deregulated and active in subsets of BTC cases or cell lines.
The association between the mesenchymal marker vimentin and Wnt pathway activation is of special interest, since tumour metastasis is believed to be dependent on an epithelialmesenchymal transition (EMT) providing the cancer cells with cell motility and invasive capacity. Wnt signalling has been implicated in EMT of colon carcinoma (48) and is regarded as one of the important signalling mechanisms to induce EMT (6, 49) . For the experimental model as well as for human BTC we show a clear correlation between active Wnt signalling and a mesenchymal, i.e. high vimentin phenotype.
To provide data on the potential of Wnt pathways inhibition, we demonstrate DMAT to efficiently reduce viability in all cell lines. DMAT is a cell-permeable inhibitor of casein kinase-2 (CK2) (50) which is crucial for active Wnt signalling (51) (52) (53) . The functions of CK2 are not restricted to Wnt signalling, e.g. activation of NFκB or PTEN (54) , and DMAT is not exclusively specific for CK2 (50) . Nevertheless, the cytotoxic effects of DMAT can be attributed to inhibition of Wnt signalling, because the efficiency of DMAT significantly correlated with cytoplasmatic ßCat (Fig. 3B) . Additionally, DMAT efficiency was high in BTC cells with high proliferation and low cytokeratin immunoreactivity which is in accordance with the above-mentioned relationships between active Wnt pathway and high proliferation or low differentiation status. The specificity to inhibit Wnt signalling is proven by DMAT's ability to down-regulate ßCat in a significant portion of cells (Fig. 3D) . To provide insight into the cytotoxic mechanisms of DMAT we analysed the activity of caspase-3 which is an effector caspase in the apoptotic cascade. For CCLP-1 cells (Fig. 3C ) a clear timedependent increase of caspase-3 activity is observable in contrast to the Wittier cell line for which the cytotoxic effect is much smaller. Taken together, DMAT is highly cytotoxic in BTC cell lines with active Wnt pathway and its cytotoxic effects are mediated by induction of apoptosis.
In summary, we demonstrate that i) the Wnt pathway is active to a different extent in BTC cell lines both in vitro and in vivo, ii) Wnt activation assessed by cytoplasmatic/nuclear localisation of ßCat is linked with a phenotype characterized by high proliferation, low differentiation (i.e. low Ck/ E-cadherin expression), mesenchymal features (high vimentin) as well as solid tumour morphology, iii) deregulated/active Wnt signalling can be detected in human BTC samples (tissue microarray) and correlates with aggressive tumour behaviour, and, iv) targeting the Wnt pathway via CK2 inhibition is highly effective in all BTC cell lines, works via induction of apoptotic cell death and the intracellular localisation of ßCat is a predictive factor for cytotoxic efficiency. The Wnt pathway therefore is a promising target for future molecular therapy of BTC.
